Apriem Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-4,240
| Closed | -$223K | – | 296 |
|
|
2017
Q1 | $223K | Sell |
4,240
-570
| -12% | -$30K | 0.06% | 116 |
|
|
2016
Q4 | $232K | Sell |
4,810
-14,980
| -76% | -$723K | 0.07% | 112 |
|
|
2016
Q3 | $1.07M | Buy |
19,790
+5,040
| +34% | +$272K | 0.32% | 51 |
|
|
2016
Q2 | $799K | Buy |
14,750
+1,780
| +14% | +$96.4K | 0.26% | 58 |
|
|
2016
Q1 | $657K | Buy |
12,970
+1,420
| +12% | +$71.9K | 0.26% | 57 |
|
|
2015
Q4 | $583K | Buy |
11,550
+1,160
| +11% | +$58.6K | 0.21% | 61 |
|
|
2015
Q3 | $499K | Sell |
10,390
-1,514
| -13% | -$72.7K | 0.18% | 65 |
|
|
2015
Q2 | $620K | Buy |
11,904
+1,842
| +18% | +$95.9K | 0.21% | 68 |
|
|
2015
Q1 | $580K | Buy |
10,062
+9,632
| +2,240% | +$555K | 0.2% | 66 |
|
|
2014
Q4 | $23K | Sell |
430
-301
| -41% | -$16.1K | 0.01% | 277 |
|
|
2014
Q3 | $42K | Buy |
731
+253
| +53% | +$14.5K | 0.02% | 222 |
|
|
2014
Q2 | $32K | Buy |
478
+48
| +11% | +$3.21K | 0.01% | 235 |
|
|
2014
Q1 | $29K | Hold |
430
| – | – | 0.01% | 264 |
|
|
2013
Q4 | $29K | Hold |
430
| – | – | 0.01% | 256 |
|
|
2013
Q3 | $27K | Sell |
430
-160
| -27% | -$10K | 0.01% | 253 |
|
|
2013
Q2 | $37K | Buy |
+590
| New | +$37K | 0.02% | 218 |
|